Cite
MLA Citation
Barbara Burtness et al.. “Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.” Lancet, vol. 394, no. 10212, 2019, pp. 1915–1928. http://access.bl.uk/ark:/81055/vdc_100161147975.0x000049